These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 37356996
1. [Dynamic monitoring of plasma Epstein-Barr Virus DNA load can predict the occurrence of lymphoproliferative disorders after haploidentical hematopoietic stem cell transplantation]. Chen J, Sun YQ, Xu LP, Zhang XH, Liu KY, Mo XD, Cheng YF, Huang XJ, Wang Y. Zhonghua Xue Ye Xue Za Zhi; 2023 Apr 14; 44(4):284-288. PubMed ID: 37356996 [Abstract] [Full Text] [Related]
2. [The diagnostic value of whole blood Epstein-Barr virus DNA load in lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation]. Niu YY, Dong YJ, Yin Y, Xu WL, Liang ZY, Wang Q, Li Y, Liu W, Ou JP, Ren HY. Zhonghua Xue Ye Xue Za Zhi; 2021 Nov 14; 42(11):904-910. PubMed ID: 35045651 [Abstract] [Full Text] [Related]
3. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment. Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T. Transpl Infect Dis; 2016 Feb 14; 18(1):44-54. PubMed ID: 26574232 [Abstract] [Full Text] [Related]
4. Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease. Gärtner BC, Schäfer H, Marggraff K, Eisele G, Schäfer M, Dilloo D, Roemer K, Laws HJ, Sester M, Sester U, Einsele H, Mueller-Lantzsch N. J Clin Microbiol; 2002 Feb 14; 40(2):351-8. PubMed ID: 11825941 [Abstract] [Full Text] [Related]
5. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation. Ruf S, Behnke-Hall K, Gruhn B, Bauer J, Horn M, Beck J, Reiter A, Wagner HJ. J Clin Virol; 2012 Mar 14; 53(3):186-94. PubMed ID: 22182950 [Abstract] [Full Text] [Related]
6. Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant. Lindsay J, Othman J, Yong MK, Ritchie D, Chee L, Tay K, Tio SY, Kerridge I, Fay K, Stevenson W, Arthur C, Chen SC, Kong DCM, Greenwood M, Pergam SA, Liu C, Slavin MA. Transpl Infect Dis; 2021 Oct 14; 23(5):e13719. PubMed ID: 34453768 [Abstract] [Full Text] [Related]
7. Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation. Lindsay J, Yong MK, Greenwood M, Kong DCM, Chen SCA, Rawlinson W, Slavin M. Rev Med Virol; 2020 Jul 14; 30(4):e2108. PubMed ID: 32301566 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus-associated risk factors for post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Quintero Bernabeu J, Juamperez J, Mercadal-Hally M, Larrarte King M, Gallego Melcon S, Gros Subias L, Sábado Álvarez C, Soler-Palacin P, Melendo Pérez S, Esperalba J, Navarro Jiménez A, Garrido Pontnou M, Camacho Soriano J, Hidalgo Llompart E, Bilbao Aguirre I, Charco Torra R. Pediatr Transplant; 2022 Sep 14; 26(6):e14292. PubMed ID: 35466492 [Abstract] [Full Text] [Related]
10. Lymphocyte subset at time of Epstein-Barr viremia post-allogeneic hematopoietic stem cell transplantation in children may predict development of post-transplant lymphoproliferative disease: CD8:CD20 ratio as a sensitive predictor. Althubaiti S, Ali S, Renzi S, Krueger J, Chiang KY, Schechter T, Punnett A, Ali M. Pediatr Transplant; 2019 Dec 14; 23(8):e13574. PubMed ID: 31496046 [Abstract] [Full Text] [Related]
11. Clinical value of plasma and peripheral blood mononuclear cells Epstein-Barr Virus DNA dynamics on prognosis of allogeneic stem cell transplantation. Zhou X, Lu X, He J, Xu Z, Li Q, Ye P, Zhong Z, Shi W, Yan H, You Y, Hu Y, Wang H. Front Cell Infect Microbiol; 2022 Dec 14; 12():980113. PubMed ID: 36189344 [Abstract] [Full Text] [Related]
12. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K. Scand J Infect Dis; 2007 Dec 14; 39(3):235-44. PubMed ID: 17366054 [Abstract] [Full Text] [Related]
13. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. Wareham NE, Mocroft A, Sengeløv H, Da Cunha-Bang C, Gustafsson F, Heilmann C, Iversen M, Kirkby NS, Rasmussen A, Sørensen SS, Lundgren JD, MATCH in PERSIMUNE study group. J Cancer Res Clin Oncol; 2018 Aug 14; 144(8):1569-1580. PubMed ID: 29804164 [Abstract] [Full Text] [Related]
14. [Monitoring of early Epstein-Barr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation]. Lu Y, Wu T, Cao XY, Wang JB, Sun Y, Zhao YL, DA WM, Ji SQ, Tong CR, Lu DP. Zhonghua Nei Ke Za Zhi; 2011 May 14; 50(5):383-7. PubMed ID: 21624219 [Abstract] [Full Text] [Related]
15. A retrospective analysis on anti-CD20 antibody-treated Epstein-Barr virus-related posttransplantation lymphoproliferative disorder following ATG-based haploidentical T-replete hematopoietic stem cell transplantation. Luo XY, Mo XD, Xu LP, Zhang XH, Wang Y, Liu KY, Chang YJ, Zhao XY, Huang XJ. Ann Hematol; 2020 Nov 14; 99(11):2649-2657. PubMed ID: 32206854 [Abstract] [Full Text] [Related]
16. The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III - Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring. Preiksaitis J, Allen U, Bollard CM, Dharnidharka VR, Dulek DE, Green M, Martinez OM, Metes DM, Michaels MG, Smets F, Chinnock RE, Comoli P, Danziger-Isakov L, Dipchand AI, Esquivel CO, Ferry JA, Gross TG, Hayashi RJ, Höcker B, L'Huillier AG, Marks SD, Mazariegos GV, Squires J, Swerdlow SH, Trappe RU, Visner G, Webber SA, Wilkinson JD, Maecker-Kolhoff B. Pediatr Transplant; 2024 Feb 14; 28(1):e14471. PubMed ID: 37294621 [Abstract] [Full Text] [Related]
17. Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness? Solano C, Mateo EM, Pérez A, Talaya A, Terol MJ, Albert E, Giménez E, Vinuesa V, Piñana JL, Boluda JCH, Navarro D. J Clin Virol; 2017 Dec 14; 97():26-32. PubMed ID: 29096390 [Abstract] [Full Text] [Related]
18. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P. Transpl Infect Dis; 2009 Oct 14; 11(5):393-9. PubMed ID: 19497070 [Abstract] [Full Text] [Related]
19. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report. Yamamoto M, Shindo M, Funayama T, Sumi C, Saito T, Toki Y, Hatayama M, Imadome KI, Mizukami Y, Okumura T. Medicine (Baltimore); 2022 Mar 25; 101(12):e29055. PubMed ID: 35357349 [Abstract] [Full Text] [Related]
20. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients. Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G. New Microbiol; 2003 Apr 25; 26(2):141-9. PubMed ID: 12737195 [Abstract] [Full Text] [Related] Page: [Next] [New Search]